Literature DB >> 32921225

A Bayesian hierarchical change point model with parameter constraints.

Hong Li1, Andreana Benitez2, Brian Neelon1.   

Abstract

Alzheimer's disease is the leading cause of dementia among adults aged 65 or above. Alzheimer's disease is characterized by a change point signaling a sudden and prolonged acceleration in cognitive decline. The timing of this change point is of clinical interest because it can be used to establish optimal treatment regimens and schedules. Here, we present a Bayesian hierarchical change point model with a parameter constraint to characterize the rate and timing of cognitive decline among Alzheimer's disease patients. We allow each patient to have a unique random intercept, random slope before the change point, random change point time, and random slope after the change point. The difference in slope before and after a change point is constrained to be nonpositive, and its parameter space is partitioned into a null region (representing normal aging) and a rejection region (representing accelerated decline). Using the change point time, the estimated slope difference, and the threshold of the null region, we are able to (1) distinguish normal aging patients from those with accelerated cognitive decline, (2) characterize the rate and timing for patients experiencing cognitive decline, and (3) predict personalized risk of progression to dementia due to Alzheimer's disease. We apply the approach to data from the Religious Orders Study, a national cohort study of aging Catholic nuns, priests, and lay brothers.

Entities:  

Keywords:  Alzheimer’s disease; Bayesian inference; block Metropolis-Hastings; change point model; parameter constraints; personalized risk prediction

Mesh:

Year:  2020        PMID: 32921225      PMCID: PMC8980247          DOI: 10.1177/0962280220948097

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  22 in total

1.  Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

Authors:  Thomas G Beach; Sarah E Monsell; Leslie E Phillips; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

2.  A Cognitive Turning Point in Development of Clinical Alzheimer's Disease Dementia and Mild Cognitive Impairment: A Biracial Population Study.

Authors:  Kumar B Rajan; Robert S Wilson; Lisa L Barnes; Neelum T Aggarwal; Jennifer Weuve; Denis A Evans
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-03-01       Impact factor: 6.053

3.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 4.  Sensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence.

Authors:  Joseph E Gaugler; Robert L Kane; Joseph A Johnston; Khaled Sarsour
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-05-17       Impact factor: 2.035

5.  A random change point model for assessing variability in repeated measures of cognitive function.

Authors:  Annica Dominicus; Samuli Ripatti; Nancy L Pedersen; Juni Palmgren
Journal:  Stat Med       Date:  2008-11-29       Impact factor: 2.373

Review 6.  Neuropathology of Alzheimer's disease.

Authors:  Daniel P Perl
Journal:  Mt Sinai J Med       Date:  2010 Jan-Feb

7.  High degree of heterogeneity in Alzheimer's disease progression patterns.

Authors:  Natalia L Komarova; Craig J Thalhauser
Journal:  PLoS Comput Biol       Date:  2011-11-03       Impact factor: 4.475

8.  Biomarkers in Alzheimer's disease: a review.

Authors:  Meena Chintamaneni; Manju Bhaskar
Journal:  ISRN Pharmacol       Date:  2012-06-28

Review 9.  Increasing Precision of Clinical Diagnosis of Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data.

Authors:  Marwan N Sabbagh; Lih-Fen Lue; Daniel Fayard; Jiong Shi
Journal:  Neurol Ther       Date:  2017-07-21

Review 10.  Therapies for Prevention and Treatment of Alzheimer's Disease.

Authors:  J Mendiola-Precoma; L C Berumen; K Padilla; G Garcia-Alcocer
Journal:  Biomed Res Int       Date:  2016-07-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.